Chemed Corporation
CHE
$459.05
$4.961.09%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.51B | 2.49B | 2.43B | 2.38B | 2.34B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.51B | 2.49B | 2.43B | 2.38B | 2.34B |
| Cost of Revenue | 1.67B | 1.62B | 1.58B | 1.53B | 1.50B |
| Gross Profit | 845.22M | 866.66M | 854.35M | 847.80M | 839.98M |
| SG&A Expenses | 412.14M | 414.07M | 419.02M | 415.21M | 412.83M |
| Depreciation & Amortization | 63.81M | 63.26M | 63.05M | 62.76M | 62.44M |
| Other Operating Expenses | -52.00K | -41.00K | 0.00 | -1.78M | -1.59M |
| Total Operating Expenses | 2.14B | 2.10B | 2.06B | 2.01B | 1.97B |
| Operating Income | 369.32M | 389.36M | 372.28M | 371.61M | 366.30M |
| Income Before Tax | 387.94M | 410.65M | 399.47M | 394.94M | 387.17M |
| Income Tax Expenses | 97.60M | 101.92M | 97.47M | 93.20M | 86.26M |
| Earnings from Continuing Operations | 290.35 | 308.74 | 302.00 | 301.73 | 300.92 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 290.35M | 308.74M | 302.00M | 301.73M | 300.92M |
| EBIT | 369.32M | 389.36M | 372.28M | 371.61M | 366.30M |
| EBITDA | 428.83M | 448.32M | 431.03M | 429.86M | 424.24M |
| EPS Basic | 19.63 | 20.73 | 20.12 | 20.00 | 19.93 |
| Normalized Basic EPS | 16.41 | 17.25 | 16.87 | 16.68 | 16.34 |
| EPS Diluted | 19.46 | 20.54 | 19.92 | 19.79 | 19.72 |
| Normalized Diluted EPS | 16.26 | 17.08 | 16.69 | 16.49 | 16.16 |
| Average Basic Shares Outstanding | 59.09M | 59.60M | 60.10M | 60.34M | 60.39M |
| Average Diluted Shares Outstanding | 59.63M | 60.18M | 60.75M | 61.03M | 61.06M |
| Dividend Per Share | 2.00 | 1.90 | 1.80 | 1.70 | 1.60 |
| Payout Ratio | 10.17% | 9.19% | 8.97% | 8.50% | 8.04% |